Transition from parenteral prostacyclins to selexipag: safety and feasibility in selected patients

There are limited data regarding the feasibility of transitioning from intravenous prostacyclins to selexipag in pulmonary arterial hypertension patients. We present a case series of successful transitions from intravenous prostacyclins to selexipag in the majority of carefully selected five stable...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldweib, Nael, Verlinden, Nathan J., Kassis-George, Hayah, Raina, Amresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504235/
https://www.ncbi.nlm.nih.gov/pubmed/34646497
http://dx.doi.org/10.1177/20458940211036623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504235/
https://www.ncbi.nlm.nih.gov/pubmed/34646497
http://dx.doi.org/10.1177/20458940211036623

Ejemplares similares